The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale

Binita Shah, Lisa Ganguzza, James Slater, Jonathan D. Newman, Nicole Allen, Edward Fisher, John Larigakis, Francisco Ujueta, Eugenia Gianos, Yu Guo, Kathleen Woolf

Research output: Contribution to journalArticle

Abstract

Background Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when compared to no intervention or usual dietary patterns. The aim of this study is to evaluate the effect of a vegan diet versus the American Heart Association (AHA)-recommended diet on inflammatory and glucometabolic profiles in patients with angiographically defined coronary artery disease (CAD). Study design This study is a randomized, open label, blinded end-point trial of 100 patients with CAD as defined by ≥ 50% diameter stenosis in a coronary artery ≥2 mm in diameter on invasive angiography. Participants are randomized to 8 weeks of either a vegan or AHA-recommended diet (March 2014 and February 2017). Participants are provided weekly groceries that adhere to the guidelines of their diet. The primary endpoint is high sensitivity C-reactive concentrations. Secondary endpoints include anthropometric data, other markers of inflammation, lipid parameters, glycemic markers, endothelial function, quality of life data, and assessment of physical activity. Endpoints are measured at each visit (baseline, 4 weeks, and 8 weeks). Dietary adherence is measured by two weekly 24-h dietary recalls, a 4-day food record during the week prior to each visit, and both plasma and urine levels of trimethylamine-N-oxide at each visit. Conclusion This study is the first to comprehensively assess multiple indices of inflammation and glucometabolic profile in a rigorously conducted randomized trial of patients with CAD on a vegan versus AHA-recommended diet.

Original languageEnglish (US)
Pages (from-to)90-98
Number of pages9
JournalContemporary Clinical Trials Communications
Volume8
DOIs
StatePublished - Dec 1 2017

Fingerprint

American Heart Association
Coronary Artery Disease
Diet
Inflammation
Coronary Vessels
Angiography
Pathologic Constriction
Quality of Life
Urine
Guidelines
Exercise
Lipids
Food
Vegans
Vegan Diet

Keywords

  • Coronary artery disease
  • Diet intervention
  • Glucose
  • Inflammation
  • Lipids

ASJC Scopus subject areas

  • Pharmacology

Cite this

The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial : Study design and rationale. / Shah, Binita; Ganguzza, Lisa; Slater, James; Newman, Jonathan D.; Allen, Nicole; Fisher, Edward; Larigakis, John; Ujueta, Francisco; Gianos, Eugenia; Guo, Yu; Woolf, Kathleen.

In: Contemporary Clinical Trials Communications, Vol. 8, 01.12.2017, p. 90-98.

Research output: Contribution to journalArticle

Shah, B, Ganguzza, L, Slater, J, Newman, JD, Allen, N, Fisher, E, Larigakis, J, Ujueta, F, Gianos, E, Guo, Y & Woolf, K 2017, 'The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale', Contemporary Clinical Trials Communications, vol. 8, pp. 90-98. https://doi.org/10.1016/j.conctc.2017.09.003
Shah, Binita ; Ganguzza, Lisa ; Slater, James ; Newman, Jonathan D. ; Allen, Nicole ; Fisher, Edward ; Larigakis, John ; Ujueta, Francisco ; Gianos, Eugenia ; Guo, Yu ; Woolf, Kathleen. / The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial : Study design and rationale. In: Contemporary Clinical Trials Communications. 2017 ; Vol. 8. pp. 90-98.
@article{5ac3d0d3e14047b1ad62a1f4367eea36,
title = "The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale",
abstract = "Background Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when compared to no intervention or usual dietary patterns. The aim of this study is to evaluate the effect of a vegan diet versus the American Heart Association (AHA)-recommended diet on inflammatory and glucometabolic profiles in patients with angiographically defined coronary artery disease (CAD). Study design This study is a randomized, open label, blinded end-point trial of 100 patients with CAD as defined by ≥ 50{\%} diameter stenosis in a coronary artery ≥2 mm in diameter on invasive angiography. Participants are randomized to 8 weeks of either a vegan or AHA-recommended diet (March 2014 and February 2017). Participants are provided weekly groceries that adhere to the guidelines of their diet. The primary endpoint is high sensitivity C-reactive concentrations. Secondary endpoints include anthropometric data, other markers of inflammation, lipid parameters, glycemic markers, endothelial function, quality of life data, and assessment of physical activity. Endpoints are measured at each visit (baseline, 4 weeks, and 8 weeks). Dietary adherence is measured by two weekly 24-h dietary recalls, a 4-day food record during the week prior to each visit, and both plasma and urine levels of trimethylamine-N-oxide at each visit. Conclusion This study is the first to comprehensively assess multiple indices of inflammation and glucometabolic profile in a rigorously conducted randomized trial of patients with CAD on a vegan versus AHA-recommended diet.",
keywords = "Coronary artery disease, Diet intervention, Glucose, Inflammation, Lipids",
author = "Binita Shah and Lisa Ganguzza and James Slater and Newman, {Jonathan D.} and Nicole Allen and Edward Fisher and John Larigakis and Francisco Ujueta and Eugenia Gianos and Yu Guo and Kathleen Woolf",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.conctc.2017.09.003",
language = "English (US)",
volume = "8",
pages = "90--98",
journal = "Contemporary Clinical Trials Communications",
issn = "2451-8654",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial

T2 - Study design and rationale

AU - Shah, Binita

AU - Ganguzza, Lisa

AU - Slater, James

AU - Newman, Jonathan D.

AU - Allen, Nicole

AU - Fisher, Edward

AU - Larigakis, John

AU - Ujueta, Francisco

AU - Gianos, Eugenia

AU - Guo, Yu

AU - Woolf, Kathleen

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Background Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when compared to no intervention or usual dietary patterns. The aim of this study is to evaluate the effect of a vegan diet versus the American Heart Association (AHA)-recommended diet on inflammatory and glucometabolic profiles in patients with angiographically defined coronary artery disease (CAD). Study design This study is a randomized, open label, blinded end-point trial of 100 patients with CAD as defined by ≥ 50% diameter stenosis in a coronary artery ≥2 mm in diameter on invasive angiography. Participants are randomized to 8 weeks of either a vegan or AHA-recommended diet (March 2014 and February 2017). Participants are provided weekly groceries that adhere to the guidelines of their diet. The primary endpoint is high sensitivity C-reactive concentrations. Secondary endpoints include anthropometric data, other markers of inflammation, lipid parameters, glycemic markers, endothelial function, quality of life data, and assessment of physical activity. Endpoints are measured at each visit (baseline, 4 weeks, and 8 weeks). Dietary adherence is measured by two weekly 24-h dietary recalls, a 4-day food record during the week prior to each visit, and both plasma and urine levels of trimethylamine-N-oxide at each visit. Conclusion This study is the first to comprehensively assess multiple indices of inflammation and glucometabolic profile in a rigorously conducted randomized trial of patients with CAD on a vegan versus AHA-recommended diet.

AB - Background Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when compared to no intervention or usual dietary patterns. The aim of this study is to evaluate the effect of a vegan diet versus the American Heart Association (AHA)-recommended diet on inflammatory and glucometabolic profiles in patients with angiographically defined coronary artery disease (CAD). Study design This study is a randomized, open label, blinded end-point trial of 100 patients with CAD as defined by ≥ 50% diameter stenosis in a coronary artery ≥2 mm in diameter on invasive angiography. Participants are randomized to 8 weeks of either a vegan or AHA-recommended diet (March 2014 and February 2017). Participants are provided weekly groceries that adhere to the guidelines of their diet. The primary endpoint is high sensitivity C-reactive concentrations. Secondary endpoints include anthropometric data, other markers of inflammation, lipid parameters, glycemic markers, endothelial function, quality of life data, and assessment of physical activity. Endpoints are measured at each visit (baseline, 4 weeks, and 8 weeks). Dietary adherence is measured by two weekly 24-h dietary recalls, a 4-day food record during the week prior to each visit, and both plasma and urine levels of trimethylamine-N-oxide at each visit. Conclusion This study is the first to comprehensively assess multiple indices of inflammation and glucometabolic profile in a rigorously conducted randomized trial of patients with CAD on a vegan versus AHA-recommended diet.

KW - Coronary artery disease

KW - Diet intervention

KW - Glucose

KW - Inflammation

KW - Lipids

UR - http://www.scopus.com/inward/record.url?scp=85029496559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029496559&partnerID=8YFLogxK

U2 - 10.1016/j.conctc.2017.09.003

DO - 10.1016/j.conctc.2017.09.003

M3 - Article

AN - SCOPUS:85029496559

VL - 8

SP - 90

EP - 98

JO - Contemporary Clinical Trials Communications

JF - Contemporary Clinical Trials Communications

SN - 2451-8654

ER -